Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 50090-7324

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-7324). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

FDA Label Image

Image-02 (Image 02)

Image-02 (Image 02)
This text includes information on special populations with hepatic and renal impairments, CYP2D6 polymorphism, age, gender, and metabolizer status affecting the drug venlafaxine. It also mentions fold change, 90% CI, and change relative to a reference value in PK analysis. The data provided seems to be related to the pharmacokinetics of different forms of venlafaxine in various scenarios.*
FDA Label Image

Image-03 (Image 03)

Image-03 (Image 03)
This appears to be a list showing the PK (pharmacokinetic) fold change and 90% confidence intervals for various drug analytes when interacting with different drugs like ethanol, venlafaxine, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The data includes information on changes in Cmax (maximum concentration) and AUC (area under the curve) values for these drug interactions.*
FDA Label Image

Image-04 (Image 04)

Image-04 (Image 04)
This text appears to list a variety of interacting drugs and analytes, including names like Diazepam, Alprazolam, Metoprolol, Risperidone, Imipramine, Haloperidol, Caffeine, Tolbutamide, and Lithium. It also mentions active moieties and fold changes with corresponding confidence intervals. The information provided seems to be related to drug interactions and measurements in a clinical or research setting.*
FDA Label Image

Label Image (Lbl500907324)

Label Image (Lbl500907324)
This text provides information about a product with a product number 58227-0 containing YENLArAxTvE HYDROCHLORIDE in extended-release form at 156 MG+. It also mentions 90 capsules and instructs to store at a specific location: 68707 OkGneEs.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.